<code id='16D7118CFB'></code><style id='16D7118CFB'></style>
    • <acronym id='16D7118CFB'></acronym>
      <center id='16D7118CFB'><center id='16D7118CFB'><tfoot id='16D7118CFB'></tfoot></center><abbr id='16D7118CFB'><dir id='16D7118CFB'><tfoot id='16D7118CFB'></tfoot><noframes id='16D7118CFB'>

    • <optgroup id='16D7118CFB'><strike id='16D7118CFB'><sup id='16D7118CFB'></sup></strike><code id='16D7118CFB'></code></optgroup>
        1. <b id='16D7118CFB'><label id='16D7118CFB'><select id='16D7118CFB'><dt id='16D7118CFB'><span id='16D7118CFB'></span></dt></select></label></b><u id='16D7118CFB'></u>
          <i id='16D7118CFB'><strike id='16D7118CFB'><tt id='16D7118CFB'><pre id='16D7118CFB'></pre></tt></strike></i>

          entertainment

          entertainment

          author:entertainment    Page View:7
          A scientist working at SQZ Biotechnologies in Watertown's Arsenal Yards. -- biotech coverage from STAT
          A scientist working at SQZ Biotechnologies in Watertown, Mass. David L Ryan/Globe Staff

          Next stop: Beacon Hill.

          Governor Maura Healey’s long-awaited plan to double down on state funding for the biotech and medical technology sector came into focus Thursday with the announcement she’ll seek $1 billion over the next decade to reauthorize the state’s 16-year-old life sciences initiative.

          advertisement

          But lawmakers so far are noncommittal on funding the plan. The proposal — dubbed “Life Sciences 3.0″ — is part of a larger economic development bill the Healey administration is expected to file soon. Several expressed support for an industry in which Massachusetts is a leader, but also noted the spending request comes at a time of competing priorities.

          Get unlimited access to award-winning journalism and exclusive events.

          Subscribe Log In

          explore

          DIEP, the 'gold standard' of breast reconstruction, is under threat
          DIEP, the 'gold standard' of breast reconstruction, is under threat

          AdobeIn1983,Iflewhomefromcollegetobewithmymotherasshewokeupfromamastectomy.Sheoptedoutofbreastrecons

          read more
          Annovis Bio delivers candor, but not confidence, on Parkinson’s study
          Annovis Bio delivers candor, but not confidence, on Parkinson’s study

          MollyFerguson/STATAnnovisBiohadmybiotechbull%^&!meterrunningredafteritmadealatechangetothedesign

          read more
          Virginia high school admissions case could be legal follow
          Virginia high school admissions case could be legal follow

          3:24DemonstratorsprotestoutsideoftheSupremeCourtinWashington,Thursday,June29,2023,aftertheSupremeCou

          read more

          David Ricks of Eli Lilly: best biopharma CEO of 2023

          HyacinthEmpinado/STATIt’sthattimeoftheyearagainwhenIrecognizetheBestBiopharmaCEOoftheyear.Thisyear’s